¡¡¡¡Pharmaceutical intermediate manufacturers. The company specializes in the research and development, production, and sales of pharmaceutical intermediates, photosensitive material intermediates, and solar conductive pastes. The main customers of pharmaceutical intermediates are domestic and foreign pharmaceutical manufacturers, the main customers of photosensitive material intermediates are color photosensitive material manufacturers, and the main customers of solar conductive paste are solar cell factories and component factories.
¡¡¡¡The competition in the advanced pharmaceutical intermediate market is relatively mild. Advanced intermediates have relatively high added value and are the main targets for pharmaceutical companies to outsource and customize production. They have significant product differentiation, high user stickiness, improved bargaining power, and relatively mild competition.
¡¡¡¡There are many types of pharmaceutical intermediates, mostly developed specifically for a certain type of raw material or formulation. Due to the specificity of the product used and the high initial investment, there are not many manufacturers in the market that produce a certain type of pharmaceutical intermediate, usually two to three. The product quality has a relative advantage. The company's existing products have obvious advantages over its competitors. For example, the main products, the anti AIDS drug intermediates aza and FADCP, have a market share of 55-60% in the domestic market. The products have good color, purity higher than those of other manufacturers, and the control of single impurities has reached the lowest level. Collaborate to develop advanced intermediates. In recent years, the company has vigorously developed quinolone drug intermediates and collaborated with universities to develop chiral drug intermediates. At present, the projects under cooperation include: the intermediate of abacavir (1R, 4S) -1-amino-4-hydroxymethyl-2-cyclopentene hydrochloride, an anti AIDS drug, which is cooperated with Beijing University of Chemical Technology, and (2S) - cis hydroxylactam, which is cooperated with East China University of Science and Technology.
